EFFECT OF L. CASEI DG® (LACTOBACILLUS PARACASEI CNCM I-1572) IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER PILOT STUDY.. EFFECT OF L. CASEI DG® IN PATIENTS WITH IRRITABLE BOWEL SYNDROME.
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
We conducted a multicentre, randomized, double-blind, crossover, eighteen-week, placebo-controlled, pilot trial assessing the effect of L. casei DG® (Enterolactis plus®) on gut microbiota composition in patients with irritable bowel syndrome (IBS).
创建时间：
2018-02-21
